Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from PuraPharm Corp. Ltd. ( (HK:1498) ) is now available.
PuraPharm Corporation Limited announced a discloseable transaction involving the disposal of accounts receivables by its indirect wholly owned subsidiary, Nong’s Company Limited, to Intrabase Financial Services Limited for HK$15,000,000. This transaction, which falls under the Listing Rules due to its applicable percentage ratios, is expected to impact the company’s financials by potentially altering its cash flow and balance sheet. The agreement includes provisions for adjustments based on the actual collection of the receivables, with the company guaranteeing the seller’s obligations.
More about PuraPharm Corp. Ltd.
PuraPharm Corporation Limited is a company incorporated in the Cayman Islands, operating with limited liability. It is involved in the industry of traditional Chinese medicine and health products, focusing on the development, manufacturing, and sale of Chinese medicine products.
Average Trading Volume: 113,976
Technical Sentiment Signal: Sell
Current Market Cap: HK$193.5M
See more insights into 1498 stock on TipRanks’ Stock Analysis page.